GenoKey

Aalborg, Denmark Founded: 2010 • Age: 16 yrs Acquired By Precisionlife
Provider of combinatorial analysis of genomic and other clinical data
Request Access

About GenoKey

GenoKey is a company based in Aalborg (Denmark) founded in 2010 by Mette Sogaard was acquired by Precisionlife in March 2021.. The company has 1 employees as of June 30, 2020. GenoKey operates in a competitive market with competitors including Tessera Therapeutics, Phase Genomics, Hexagon Bio, NovellusDx and SeqOne, among others.

  • Headquarter Aalborg, Denmark
  • Employees 1 as on 30 Jun, 2020
  • Founders Mette Sogaard
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Genokey Aps
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    1

    as on Jun 30, 2020

  • Acquired by
    Precisionlife

    (Mar 24, 2021)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of GenoKey

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in GenoKey

GenoKey has secured backing from 1 investor. Prominent investors backing the company include Precisionlife. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Investor Description Founded Year Domain Location
AI-enabled platforms for drug discovery and precision medicine are developed.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by GenoKey

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - GenoKey

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Genokey Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of GenoKey

GenoKey operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tessera Therapeutics, Phase Genomics, Hexagon Bio, NovellusDx and SeqOne, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
New genome engineering technology is provided for treating multiple diseases.
domain founded_year HQ Location
Laboratory and computational services for DNA proximity analysis are provided.
domain founded_year HQ Location
Bioinformatics tools are provided for analyzing microbial genomic sequencing data.
domain founded_year HQ Location
Developer of technology for precision cancer diagnosis and therapies
domain founded_year HQ Location
Bioinformatics tools for genome sequencing data analysis are provided.
domain founded_year HQ Location
Provider of genomic DNA tests for assessing predisposition to diseases & personalized nutrition
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Genokey

Frequently Asked Questions about GenoKey

When was GenoKey founded?

GenoKey was founded in 2010.

Where is GenoKey located?

GenoKey is headquartered in Aalborg, Denmark.

How many employees does GenoKey have?

As of Jun 30, 2020, the latest employee count at GenoKey is 1.

What does GenoKey do?

GenoKey was founded in 2010 in Aalborg, Denmark, within the healthcare and genomics sector. Services encompass DNA sequencing and electronic medical record data mining. Correlations between genotypic, phenotypic, clinical, and environmental data are enabled, with management of extensive research datasets included. Operations focus on supporting healthcare applications through integrated data analysis.

Who are the top competitors of GenoKey?

GenoKey's top competitors include Tessera Therapeutics, Phase Genomics and SeqOne.

Who are GenoKey's investors?

GenoKey has 1 investor. Key investors include Precisionlife.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available